CAR-T Meeting 2025 | Improving access to CAR-T in Europe: training HCPs and developing the CAR-T passport
In this video, Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, briefly comments on the access to CAR T-cell therapy in Europe, stating that while access is improving, it is not yet equal across countries due to various barriers. Dr Chabannon emphasizes the need to gather resources, including human resources and trained personnel, to overcome these challenges and highlights the efforts of the GoCART coalition to revise the CAR-T Handbook and develop a CAR-T passport for healthcare professionals (HCPs) treating patients with this therapy. This interview took place at the EHA-EBMT 7th European CAR T-cell Meeting, held in Strasbourg, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript (AI-generated)
I do believe that the access to CAR-T and probably the efficacy of CAR-T is improving as professionals, and patients actually, gain more experience. But the access is definitely not equal across countries for a variety of reasons that are not only medical in nature but could be regulatory issues, financial issues. So we keep working on these aspects trying to improve access...
I do believe that the access to CAR-T and probably the efficacy of CAR-T is improving as professionals, and patients actually, gain more experience. But the access is definitely not equal across countries for a variety of reasons that are not only medical in nature but could be regulatory issues, financial issues. So we keep working on these aspects trying to improve access.
We believe one very important aspect is gathering all the needed resources, including human resources, at treating hospitals and having well-trained people is a most important aspect on which the GoCART Coalition is working. We are revising the CAR-T Handbook which will support the development of the CAR-T passport which is sort of a driving license for different categories of professionals involved in treating patients with CAR-T cells.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
